EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Inhibitory, Anticancer Efficacy and Structural Insights of a Novel Ethyl 1‐Hydroxy‐3‐Oxo‐1‐Phenylisoindoline‐2‐Sulfonate Compound Selectively Targeting Human CA IX and CA XII Carbonic Anhydrase, Ferroptosis‐Mediated Cell Death

Funda Keteci, Songul Bayrak iD, Ufuk Atmaca iD, Mustafa Özkaraca, Azada Aliyeva, Buket Bakan iD

Cell Biochemistry and Function · 2026-11 · 44 (11)

DOI: 10.1002/cbf.70336 ↗

At a glance

Journal article in Cell Biochemistry and Function, published online on 2026-11-02. Written by Funda Keteci and 5 co-authors. Institution: Department of Molecular Biology and Genetics, Atatürk University, Erzurum, Turkey. Major MEDLINE topics: Carbonic Anhydrase Inhibitors, Antineoplastic Agents, Carbonic Anhydrases, Carbonic Anhydrase IX. 54 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Carbonic anhydrase (CA) isoforms IX and XII are critical in anticancer drug development due to their essential roles in regulating pH and hypoxic conditions. In this study, the inhibitory potential of ethyl‐1‐hydroxy‐3‐oxo‐1‐phenylisoindoline‐2‐sulfonate (1), synthesized via click chemistry, was evaluated against hCA IX and hCA XII. The cellular effects of compound on human breast cancer (MCF‐7 cells) were investigated using a combination of viability, oxidative stress, and molecular level. Compound exhibited stronger inhibitory activity than the acetazolamide (AAZ), with K i values of 11.48 ± 4.18 nM for hCA IX and 9.32 ± 2.35 nM for hCA XII. The compound exhibited a higher binding affinity to hCA IX with −8.8 kcal/mol docking score. While no cytotoxic effect was observed on MCF‐10A cells, a significant dose‐dependent reduction was observed in cell viability, confirmed loss of membrane integrity in cancer cells. ROS levels were decreased at higher concentrations, indicating that the toxicity was independent of ROS production. Caspase‐3 and LC3B expression showed strong positivity at moderate concentrations, suggesting activation of apoptotic and autophagic pathways. GPX4 and TFRC fluorescence intensities were markedly decreased that disruption of redox homeostasis and iron metabolism. These findings indicate that compound is a promising lead molecule for the development of next‐generation anticancer agents targeting tumor‐associated CA isoforms.

Subjects

MeSH terms (MEDLINE)

Carbonic Anhydrase InhibitorsAntineoplastic AgentsCarbonic AnhydrasesCarbonic Anhydrase IXFerroptosisAntigens, NeoplasmIsoindolesHumansMCF-7 CellsDrug Screening Assays, AntitumorCell SurvivalStructure-Activity RelationshipCell DeathMolecular Docking SimulationMolecular Structure

Author keywords

biochemistrycarbonic anhydrasecell deathenzyme inhibitionisoindolinone

Substances

Carbonic Anhydrase InhibitorsAntineoplastic AgentsCarbonic AnhydrasesCarbonic Anhydrase IXcarbonic anhydrase XIIAntigens, NeoplasmCA9 protein, humanIsoindoles

Authors and institutions

  • Department of Molecular Biology and Genetics, Atatürk University, Erzurum, Turkey.
  • Department of Chemistry, Faculty of Sciences, Atatürk University, Erzurum, Turkey.
  • Department of Pathology, Faculty of Veterinary Medicine, Cumhuriyet University, Sivas, Turkey.

ORCID profiles: Songul Bayrak, Ufuk Atmaca, Buket Bakan

Cite

APA

Keteci, F., Bayrak, S., Atmaca, U., Özkaraca, M., Aliyeva, A., & Bakan, B. (2026). Inhibitory, Anticancer Efficacy and Structural Insights of a Novel Ethyl 1‐Hydroxy‐3‐Oxo‐1‐Phenylisoindoline‐2‐Sulfonate Compound Selectively Targeting Human CA IX and CA XII Carbonic Anhydrase, Ferroptosis‐Mediated Cell Death. Cell Biochemistry and Function, 44(11). https://doi.org/10.1002/cbf.70336

Vancouver

Keteci F, Bayrak S, Atmaca U, Özkaraca M, Aliyeva A, Bakan B. Inhibitory, Anticancer Efficacy and Structural Insights of a Novel Ethyl 1‐Hydroxy‐3‐Oxo‐1‐Phenylisoindoline‐2‐Sulfonate Compound Selectively Targeting Human CA IX and CA XII Carbonic Anhydrase, Ferroptosis‐Mediated Cell Death. Cell Biochemistry and Function. 2026;44(11). doi:10.1002/cbf.70336

BibTeX
@article{Keteci2026,
  author = {Keteci, Funda and Bayrak, Songul and Atmaca, Ufuk and Özkaraca, Mustafa and Aliyeva, Azada and Bakan, Buket},
  title = {Inhibitory, Anticancer Efficacy and Structural Insights of a Novel Ethyl 1‐Hydroxy‐3‐Oxo‐1‐Phenylisoindoline‐2‐Sulfonate Compound Selectively Targeting Human CA IX and CA XII Carbonic Anhydrase, Ferroptosis‐Mediated Cell Death},
  journal = {Cell Biochemistry and Function},
  year = {2026},
  volume = {44},
  number = {11},
  doi = {10.1002/cbf.70336}
}
Start for free →